Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism

Clin Endocrinol (Oxf). 1982 Jul 1;17(1):21-8. doi: 10.1111/j.1365-2265.1982.tb02630.x.

Abstract

Oral administration of prednisone (30 mg/day for 9 days) to six normal individuals induced a significant rise in the concentration of serum 1,25-dihydroxyvitamin D [1,25-(OH)2D] within 2 days. In four patients with primary hyperparathyroidism a larger increase of 1,25-(OH)-2D was observed within 3 days. In these patients the 1,25-(OH)-2D concentration remained elevated during the whole period of prednisone administration (10 days) whereas in the control group it had returned to basal levels or below after 9 days of prednisone administration. This response appeared dependent upon parathyroid hormone (PTH) as we found no change in the (basally low) 1,25-(OH)2D concentrations in five patients with hypoparathyroidism during 3-4 days of prednisone administration (30 mg/day). In these patients vitamin D medication had been interrupted 3-5 days before the administration of prednisone, whereafter serum calcium was kept between 2.10 and 2.30 mmol/1 by means of calcium infusion. The response of 1,25-(OH)2D to prednisone is best explained by a stimulatory action of glucocorticoids upon PTH secretion or by the induction of increased PTH sensitivity.

MeSH terms

  • 24,25-Dihydroxyvitamin D 3
  • 25-Hydroxyvitamin D 2
  • Adult
  • Aged
  • Calcitriol / blood*
  • Dihydroxycholecalciferols / blood
  • Ergocalciferols / analogs & derivatives
  • Ergocalciferols / blood
  • Female
  • Humans
  • Hyperparathyroidism / blood*
  • Hypoparathyroidism / blood*
  • Male
  • Middle Aged
  • Prednisone / pharmacology*

Substances

  • Dihydroxycholecalciferols
  • Ergocalciferols
  • 25-Hydroxyvitamin D 2
  • 24,25-Dihydroxyvitamin D 3
  • Calcitriol
  • Prednisone